The proposed link between caffeine and reductions in the beta amyloid plaque accumulation characteristic of Alzheimer’s disease (AD) suggest a possible role for caffeine in AD treatment.

The latest evidence linking beta amyloid protein to Alzheimer’s disease and exploring the relationship between caffeine and beta amyloid are featured in a review article in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science.

In the article “Caffeine as Treatment for Alzheimer’s: A Review”, Abhishek Mohan, BS, Old Dominion University (Norfolk, Va.), and coauthors identify the potential opportunities for using caffeine to reduce beta amyloid levels as a means of preventing, treating, and slowing the progression of Alzheimer’s disease.

READ FULL ARTICLE Curated publisher From Medical News Today